Evolution of serum β2-microglobulin concentrations during treatment of tuberculosis patients

Scandinavian Journal of Infectious Diseases

Volumn 31, Issue 3, 1999, Pages 265-267

  Collazos, Julio ^a   Martínez, Eduardo ^a   Mayo, Jose ^a  

^a HOSPITAL DE GALDAKAO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION FUNCTION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; LUNG TUBERCULOSIS; MALE; BLOOD; IMMUNOCOMPETENCE; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SERODIAGNOSIS; TUBERCULOSIS; TUBERCULOUS PLEURISY;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; FEMALE; HIV SERONEGATIVITY; HUMANS; IMMUNOCOMPETENCE; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS, PLEURAL; TUBERCULOSIS, PULMONARY;

EID: 0032587837     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365549950163554     Document Type: Article

References (19)

1. Carstens J, Andersen PL. Changes in serum neopterin and serum beta-2-microglobulin in subjects with lung infections. Eur Respir J 1994; 7: 1233-8.
2. Turner BJ, Hecht FM, Ismail RB. CD4+ T-lymphocyte measures in the treatment of individuals infected with human immunodeficiency virus type 1. A review for clinical practitioners. Arch Intern Med 1994; 154: 1561-73.
3. Gazapo E, Gazapo RM, Caturla A. Utilidad clínica de la determinación de beta-2-microglobulina. Med Clin (Barc) 1996; 106: 751-5.
4. Söderblom T, Nyberg P, Pettersson T, Klockars M, Riska H. Pleural fluid beta-2-microglobulin and angiotensin-converting enzyme concentrations in rheumatoid arthritis and tuberculosis. Respiration 1996; 63: 272-6.
5. Riska H, Pettersson T, Fröseth B, Klockars M. β2 microglobulin in pleural effusions. Acta Med Scand 1982; 211: 45-50.
6. Kennedy N, Whitelaw FM, Gutmann J, Berger L, Uiso L, Ngowi FI, et al. Clinical features and serum β2-microglobulin levels in HIV-1 positive and negative Tanzanian patients with tuberculosis. Int J STD AIDS 1995; 6: 278-83.
7. Vanham G, Edmonds K, Qing L, Hom D, Toossi Z, Jones B, et al. Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection. Clin Exp Immunol 1996; 103: 30-4.
8. Richter C, Koelemay MJW, Swai ABM, Perenboom R, Mwakyusa DH, Oosting J. Predictive markers of survival in HIV-seropositive and HIV-seronegative Tanzanian patients with extrapulmonary tuberculosis. Tuber Lung Dis 1995; 76: 510-7.
9. Thybo S, Richter C, Wachmann H, Maselle SY, Mwakyusa DH, Mtoni I, et al. Humoral response to Mycobacterium tuberculosis-specific antigens in African tuberculosis patients with high prevalence of human immunodeficiency virus infection. Tuber Lung Dis 1995; 76: 149-55.
10. Richter C, Perenboom R, Mtoni I, Kitinya J, Chande H, Swai ABM, et al. Clinical features of HIV-seropositive and HIV-seronegative patients with tuberculous pleural effusion in Dar es Salaam, Tanzania. Chest 1994; 106: 1471-5.
11. Richter C, Pallangyo KJ, Ndosi BN, Chum HJ, Swai ABM, Shao J. Chest radiography and β-2-microglobulin levels in HIV-seronegative and HIV-seropositive African patients with pulmonary tuberculosis. Trop Geogr Med 1994; 46: 283-7.
12. Wallis RS, Vjecha M, Amir-Tahmasseb M, Okwera A, Byekwaso F, Nyole S, et al. Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated β2-microglobulin in HIV-1-associated tuberculosis. J Infect Dis 1993; 167: 43-8.
13. Egboga A, Corrah T, Todd J, Wilkins A, Whittle H, Bouchier V, et al. Immunological findings in African patients with pulmonary tuberculosis and HIV-2 infection. AIDS 1992; 6: 1045-6.
14. Nunn P, Brindle L, Carpenter L, Odhiambo J, Wasunna K, Newnham R, et al. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality. Am Rev Respir Dis 1992; 146: 849-54.
15. Inostroza J, Muñoz P, Espinoza R, Millaqueo L, Diaz P, Leiva L, et al. Quantitation of soluble HLA class I heterodimers and beta 2-microglobulin in patients with active pulmonary tuberculosis. Hum Immunol 1994; 40: 179-82.
16. Wallis RS, Helfand MS, Whalen CC, Johnson JL, Mugerwa RD, Vjecha M, et al. Immune activation, allergic drug toxicity and mortality in HIV-positive tuberculosis. Tuber Lung Dis 1996; 77: 516-23.
17. Wallis RS, Nsubuga P, Whalen C, Mugerwa RD, Okwera A, Oette D, et al. Pentoxifilline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: a randomized controlled trial. J Infect Dis 1996; 174: 727-33.
18. Lafeuillade A, Tamalet C, Pellegrino P, de Micco P, Vignoli C, Quilichini R. Correlation between surrogate markers, viral load, and disease progression in HIV-1 infection. J Acquir Immune Defic Syndr 1994; 7: 1028-33.
19. Tsoukas CM, Bernard NF. Markers predicting progression of human immunodeficiency virus-related disease. Clin Microbiol Rev 1994; 7: 14-28.